Unknown OBSERVATIONAL NCT04305704

Coated Mongolian Aneurysm Treatment Study 2 (COMATS 2)

Clinical Evaluation of the p64 MW HPC and the p48 MW HPC Flow Diverters in an Observational Registry

Sponsor: Phenox GmbH

Conditions Aneurysm Intracranial Aneurysm Vascular Diseases

Updated 7 times since 2020 Last updated: Apr 19, 2022 Started: Feb 8, 2020 Primary completion: Feb 28, 2023 Completion: Dec 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04305704, this observational or N/A phase trial focuses on Aneurysm and Intracranial Aneurysm and remains ongoing. Sponsored by Phenox GmbH, it has been updated 7 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
May 2024 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
May 2022 — May 2024 [monthly]

Recruiting
Apr 2021 — May 2022 [monthly]

Recruiting

▶ Show 2 earlier versions

Jan 2021 — Apr 2021 [monthly]

Recruiting
Apr 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Phenox GmbH

Data source: Phenox GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ulaanbaatar, Mongolia